AGCM-22, a novel cetuximab-based EGFR-targeting antibody-drug-conjugate with highly selective anti-glioblastoma efficacy
Dapeng Li, Xianyan Sun, Yiquan Li, Chao Shang, Yuchao Dong, Renshuang Zhao, Hang Zhang, Zihao Wang, Shiyong Fan, Chengyuan Ma, Xiao Li
Topics & Concepts
CetuximabAntibody-drug conjugateTemozolomideEpidermal growth factor receptorCancer researchChemistryPharmacologyAntibodyMonoclonal antibodyCytotoxic T cellIn vitroMedicineGliomaImmunologyReceptorBiochemistryGlioma Diagnosis and TreatmentCAR-T cell therapy researchNeuroblastoma Research and Treatments